Alpha-9 Theranostics Inc.

About

This is a clinical-stage radiopharmaceutical company, developing new theranostic (diagnostic and therapeutic) products that can change how cancer is treated. The scientific founders of Alpha-9 have significant know-how and are considered world experts in radiopharmaceuticals, chemistry, and molecular design. The Company’s focus is on the effective treatment of metastatic cancer. They are developing a breakthrough in chemistry that now enables something not previously possible, a simple, one-step attachment of fluorine-18, considered the best imaging agent, to any peptide or protein cancer-targeting agent. This technology can significantly expand the PETscan market.